Percutaneous dilatational tracheostomy following total artificial heart implantation

Interact Cardiovasc Thorac Surg. 2015 Jul;21(1):117-8. doi: 10.1093/icvts/ivv071. Epub 2015 Mar 25.

Abstract

Coagulation disorders and an immune-altered state are common among total artificial heart patients. In this context, we sought to evaluate the safety of percutaneous dilatational tracheostomy in cases of prolonged need for mechanical ventilatory support. We retrospectively analysed the charts of 11 total artificial heart patients who received percutaneous dilatational tracheostomy. We focused on early and late complications. We observed no major complications and no procedure-related deaths. Early minor complications included venous oozing (45.4%) and one case of local infection. Late complications, including subglottic stenosis, stomal infection or infections of the lower respiratory tract, were not observed. In conclusion, percutaneous dilatational tracheostomy in total artificial heart patients is safe. Considering the well-known benefits of early tracheotomy over prolonged translaryngeal intubation, we advocate early timing of therapy in cases of prolonged mechanical ventilation.

Keywords: Artificial heart; Respiratory insufficiency; Tracheostomy.

MeSH terms

  • Adult
  • Aged
  • Cardiomyopathies / complications*
  • Cardiomyopathies / diagnosis
  • Cardiomyopathies / physiopathology
  • Dilatation
  • Female
  • Heart Failure / diagnosis
  • Heart Failure / etiology
  • Heart Failure / physiopathology
  • Heart Failure / surgery*
  • Heart, Artificial*
  • Humans
  • Intubation, Intratracheal
  • Male
  • Middle Aged
  • Postoperative Complications / etiology
  • Prosthesis Implantation / adverse effects
  • Prosthesis Implantation / instrumentation*
  • Respiration, Artificial
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Tracheostomy / adverse effects
  • Tracheostomy / methods*
  • Treatment Outcome